PulmoEase Respules
₹385
Packaging: Box of 10 sterile respules (3ml each) in tamper-evident aluminum foil pouches
Pack Type: gel
Composition:
Levosalbutamol 1.25mg + Ipratropium Bromide 500mcg per respule
Indication:
Management of bronchospasm in asthma, COPD, and reversible obstructive airway diseases; provides relief from acute wheezing, breathlessness, and chest tightness.
Description:
PulmoEase Respules deliver a powerful dual-action formula combining Levosalbutamol and Ipratropium Bromide for comprehensive respiratory relief. This ready-to-use nebulization solution works through complementary mechanisms to open airways and improve breathing.
Each sterile respule contains precisely measured medication that targets both the symptoms and underlying causes of bronchospasm. The solution quickly disperses through nebulization, reaching deep into the lungs for fast-acting relief that lasts up to 6 hours.
Mechanism of Action
- Levosalbutamol: Selectively stimulates beta2-adrenergic receptors in bronchial smooth muscle for bronchodilation
- Ipratropium Bromide: Blocks muscarinic cholinergic receptors, preventing bronchoconstriction
Tags:
- Rapid relief from acute breathing difficulties and bronchospasm
- Dual-action formula treats both smooth muscle constriction and cholinergic bronchoconstriction
- Ready-to-use sterile respules eliminate preparation time
- Extended relief period of 4-6 hours between doses
Usage Information
Dosage
Adults and children 12 years and above: Inhale contents of one respule via nebulizer every 6-8 hours as needed. Children 6-12 years: As directed by physician, typically half respule contents. Maximum 4 respules in 24 hours. Shake gently before use.
Side Effects
Common side effects include temporary nervousness, trembling, headache, increased heart rate, and dry mouth. Less common side effects include dizziness, nausea, and throat irritation. Rare but serious side effects include allergic reactions and paradoxical bronchospasm.
Contraindications
Not suitable for individuals with hypersensitivity to Levosalbutamol, Ipratropium Bromide, or any component of the formulation. Use with caution in patients with cardiovascular disorders, hypertension, diabetes mellitus, or glaucoma.
